This is one of multiple CGM devices that are hitting the market in the next 6-12 months... the market window is closing quickly for the UBand and there seems to be no progress.
The device you linked to, the Senseonics Eversense CGM 180-day monitor, is still an invasive monitor which includes a sensor that must be implanted under the skin 2-3 times per year by a doctor. This seems like an expensive and uncomfortable solution... the fact that alot of people will likely use this device highlights the tremendous market opportunity that the UBand would address if it ever sees the light of day.
News 
Market Data 
Discover 
AI
